Zhengye Biotechnology Holding (ZYBT) Total Debt (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) reported Total Debt of $10.4 million for Q4 2025, down 5.49% year-over-year from $11.0 million in Q4 2024, and up 1439.09% quarter-over-quarter from $677438.4 in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Total Debt (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has 3 years of Total Debt data on file, last reported at $10.4 million in Q4 2025.
- Total Debt for Q4 2025 came in at $10.4 million, down 5.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.4 million (down 5.49% YoY), and the FY2025 annual result was $10.3 million, down 5.22% from the prior year.
- Total Debt improved to $10.4 million in Q4 2025 per ZYBT's latest filing, from $677438.4 in the prior quarter.
- Over five years, Total Debt peaked at $11.1 million in Q4 2023 and troughed at $677438.4 in Q2 2025.
- A 3-year average of $8.3 million and a median of $10.7 million in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2024 and 2025: Total Debt slipped 1.03% in 2024, then retreated 5.49% in 2025.
- A 3-year view of Total Debt shows it stood at $11.1 million in 2023, then decreased by 1.03% to $11.0 million in 2024, then decreased by 5.49% to $10.4 million in 2025.
- Business Quant data shows ZYBT's Total Debt at $10.4 million in Q4 2025, $677438.4 in Q2 2025, and $11.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.63 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.53 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.99 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.51 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 570.41 Mn |
| 10 | Zhengye Biotechnology Holding | 5.49 Mn | 6.20 Mn | - | 10.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.43 Mn |
| Jun 30, 2025 | 677,438.40 |
| Dec 31, 2024 | 11.03 Mn |
| Dec 31, 2023 | 11.15 Mn |